Literature DB >> 12461700

Toxoplasmosis, an overview with emphasis on ocular involvement.

Vincent N A Klaren1, Aize Kijlstra.   

Abstract

Toxoplasmosis is a common parasitic zoonosis and an important cause of abortions, mental retardation, encephalitis, blindness, and death worldwide. Although a large body of literature has emerged on the subject in the past decades, many questions about the pathogenesis and treatment of the disease remain unanswered. This review aims to provide an overview of the current insights regarding the causative parasite and the mechanisms leading to symptomatic infection with emphasis on ocular toxoplasmosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12461700     DOI: 10.1076/ocii.10.1.1.10330

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  15 in total

1.  Experimental ocular toxoplasmosis in genetically susceptible and resistant mice.

Authors:  Fangli Lu; Shiguang Huang; Mark S Hu; Lloyd H Kasper
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

2.  Repurposing the open access malaria box to discover potent inhibitors of Toxoplasma gondii and Entamoeba histolytica.

Authors:  Fabrice F Boyom; Patrick V T Fokou; Lauve R Y Tchokouaha; Thomas Spangenberg; Alvine N Mfopa; Ruffin M T Kouipou; Cedric J Mbouna; Valerie F Donkeng Donfack; Paul H A Zollo
Journal:  Antimicrob Agents Chemother       Date:  2014-07-21       Impact factor: 5.191

Review 3.  Corticosteroids as adjuvant therapy for ocular toxoplasmosis.

Authors:  Smitha Jasper; Satyanarayana S Vedula; Sheeja S John; Saban Horo; Yasir J Sepah; Quan Dong Nguyen
Journal:  Cochrane Database Syst Rev       Date:  2017-01-26

Review 4.  Corticosteroids as adjuvant therapy for ocular toxoplasmosis.

Authors:  Smitha Jasper; Satyanarayana S Vedula; Sheeja S John; Saban Horo; Yasir J Sepah; Quan Dong Nguyen
Journal:  Cochrane Database Syst Rev       Date:  2013-04-30

Review 5.  Toxoplasmosis: Targeting neurotransmitter systems in psychiatric disorders.

Authors:  Tooran Nayeri; Shahabeddin Sarvi; Ahmad Daryani
Journal:  Metab Brain Dis       Date:  2021-09-03       Impact factor: 3.584

Review 6.  Toxoplasma gondii and the blood-brain barrier.

Authors:  Sabrina M Feustel; Markus Meissner; Oliver Liesenfeld
Journal:  Virulence       Date:  2012-03-01       Impact factor: 5.882

7.  Clinical features of ocular toxoplasmosis in Korean patients.

Authors:  Young-Hoon Park; Jae-Hyung Han; Ho-Woo Nam
Journal:  Korean J Parasitol       Date:  2011-06-14       Impact factor: 1.341

8.  Toxoplasmosis: a global threat.

Authors:  João M Furtado; Justine R Smith; Rubens Belfort; Devin Gattey; Kevin L Winthrop
Journal:  J Glob Infect Dis       Date:  2011-07

9.  Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries.

Authors:  Jaroslav Flegr; Joseph Prandota; Michaela Sovičková; Zafar H Israili
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

10.  Risk factors for ocular toxoplasmosis in Brazil.

Authors:  A I C Ferreira; C C Brandão De Mattos; F B Frederico; C S Meira; G C Almeida; F Nakashima; C R Bernardo; V L Pereira-Chioccola; L C De Mattos
Journal:  Epidemiol Infect       Date:  2013-03-18       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.